Abvc Biopharma Inc
(ABVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 09-2008 | 06-2008 | 03-2008 | 12-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 970 | N/A | N/A | 974 |
| Other current assets | 1 | 20 | 0 | 0 | 25 |
| TOTAL | $1 | $990 | $N/A | $N/A | $1,000 |
| Non-Current Assets | |||||
| PPE Net | N/A | 90 | N/A | N/A | 76 |
| Other Non-Current Assets | 450 | 420 | 0 | 0 | 420 |
| TOTAL | $450 | $510 | $N/A | $N/A | $496 |
| Total Assets | $451 | $1,500 | $N/A | $N/A | $1,502 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 1,350 | 0 | 0 | 1,350 |
| Accrued Expenses | N/A | 10 | N/A | N/A | 10 |
| Other current liabilities | 340 | 230 | N/A | N/A | 230 |
| TOTAL | $340 | $2,740 | $N/A | $N/A | $2,742 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $340 | $2,740 | $N/A | $N/A | $2,742 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 30 | N/A | N/A | 30 |
| Retained earnings | N/A | -14,900 | N/A | N/A | -14,909 |
| Other shareholders' equity | 0 | 10 | 0 | 0 | 9 |
| TOTAL | $N/A | $-1,230 | $N/A | $N/A | $-1,240 |
| Total Liabilities And Equity | $340 | $1,510 | $0 | $0 | $1,502 |